Cargando…
Can ROMA algorithm stratify ovarian tumor patients better when being based on specific age ranges instead of the premenopausal and postmenopausal status?
After several years of research, HE4 was found to be characterized by slightly worse sensitivity but significantly higher specificity as compared with CA125. Further studies led to the diagnostic potential of both markers (CA125 and HE4) being combined in a single risk of malignancy algorithm (ROMA)...
Autores principales: | Chudecka-Głaz, Anita, Cymbaluk-Płoska, Aneta, Jastrzębska, Jolanta, Menkiszak, Janusz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4990599/ https://www.ncbi.nlm.nih.gov/pubmed/26753953 http://dx.doi.org/10.1007/s13277-015-4733-z |
Ejemplares similares
-
HE4 Serum Levels in Patients with BRCA1 Gene Mutation Undergoing Prophylactic Surgery as well as in Other Benign and Malignant Gynecological Diseases
por: Chudecka-Głaz, Anita, et al.
Publicado: (2017) -
Could HE4 level measurements during first-line chemotherapy predict response to treatment among ovarian cancer patients?
por: Chudecka-Głaz, Anita, et al.
Publicado: (2018) -
Ectopic pregnancy treatment by combination therapy
por: Cymbaluk-Płoska, Aneta, et al.
Publicado: (2016) -
Diagnostic usefulness of the Risk of Ovarian Malignancy Algorithm using the electrochemiluminescence immunoassay for HE4 and the chemiluminescence microparticle immunoassay for CA125
por: Chudecka-Głaz, Anita, et al.
Publicado: (2016) -
Risk Model in Women with Ovarian Cancer Without Mutations
por: Cymbaluk-Płoska, Aneta, et al.
Publicado: (2018)